20 Innovators Changing the Face of the Clinical Trials Industry: Donald A. Deieso, PhD, WIRB-Copernicus Group
CenterWatch names Donald A. Deieso, PhD, Chairman & CEO, WIRB-Copernicus Group, one of the 20 innovators changing the face of the clinical trials industry. To login to CenterWatch or to purchase this article, please click here. Publication: CenterWatch Monthly, Volume 20, Issue 4.
Improving IRBs: A Case Study with Copernicus Group IRB
This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in its entirety, please click here. Publication: Applied Clinical Trials
Do it Right…the First Time
This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in its entirety, please click here. Publication: Applied Clinical Trials
Arsenal Capital Acquires IRBNet, Adding Technical Service Provider to the WIRB-Copernicus Group
CenterWatch announces Arsenal Capital’s acquisition of IRBNet to add to the WIRB-Copernicus Group. Publication: CenterWatch Weekly, December 10, 2012, Page 6.
Promoting human protection in drug research on a global scale and the need for uniform standards
This contribution to Scrip Regulatory Affairs is authored by Nick Slack, MBE, Senior Vice President of Strategic Client Partnerships, WIRB-Copernicus Group. To read this article in its entirety, please login to Scrip Regulatory Affairs, by clicking here. Publication: Scrip Regulatory Affairs
Lean Six Sigma in the Clinical Trial Industry: Two Perspectives
This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in its entirety, please click here. Publication: Applied Clinical Trials